All Blogs

Sep 24, 2020

J&J commences COVID-19 vaccine phase 3 Johnson & Johnson has begun a 60,000-subject phase 3 evaluation of its COVID-19 vaccine. The trial will enroll participants in the U.S. and other countries with a high incidence of COVID-19 to generate data to bolster emergency use authorization early next year. ...

Sep 23, 2020

The amalgamation of technology and healthcare beholds tremendous opportunities to provide high-quality and affordable healthcare services. For the past few years, global healthcare companies are exploring Information and Communication Technologies (ICTs) to support and promote remote healthcare services and also to...

Sep 22, 2020

Samsung Biologics strikes a USD 330.8 Mn supply deal with AstraZeneca  Samsung Biologics announced the conclusion of a long-term supply deal with AstraZeneca worth USD 330.8 Million.  AZ has made several headlines the past few months, forming a slew of deals to manufacture and supply its products. H...

Sep 21, 2020

Each year, approximately 1.35 million people die due to vehicular or road accidents. Road crashes are also the most common cause of peripheral nerve injury (PNI), affecting the brachial BP or the radial, fibular, or sciatic nerves, typically in young motorcycle riders. These fragile and delicate nerves can be easil...

Nov 07, 2024

Cervical cancer is the fourth most common type of cancer and the fourth leading cause of death in women. According to the WHO, HPV infections contribute to an estimated 530,000 cases of cervical cancer and 264,000 related deaths annually, with over 85% of these fatalities occurring in low- and middle-income countri...

Sep 17, 2020

Lilly links COVID-19 antibody to a reduce hospitalization rate Eli Lilly has linked its anti-SARS-CoV-2 antibody to a lower rate of hospitalization in patients lately diagnosed with mild to moderate cases of COVID-19. Nevertheless, two of the three doses, including the highest studied in the phase 2 trial, flunk...

Sep 16, 2020

In today’s highly dynamic world, almost every industry is going through major transformations. Similar to other industries, the healthcare sector has also observed many changes during the last two decades. The artificial intelligence, telemedicine, telehealth, 3D-printing, robotics/ nanotechnology, augmented realit...

Sep 15, 2020

AstraZeneca/ Oxford resumes the trial of their COVID-19 vaccine in the UK After receiving a go-ahead from the UK’s Medicines Health Regulatory Authority, AstraZeneca and the University of Oxford have resumed the trials of their experimental coronavirus candidate AZD1222 in the country. A rapid review by the tria...

Nov 08, 2024

Cervical cancer stands as the fourth most diagnosed cancer among women globally, trailing breast, colorectal, and lung cancers. However, its impact is disproportionately heavy on developing nations, where prevalence rates soar. In 2022, WHO estimated approximately 660,000 new cases of cervical cancer and 350,000 de...

Sep 11, 2020

In the span of a decade, the Acromegaly pipeline therapies, including IONIS-GHR-LRx (Ionis Pharmaceuticals), ATL1103 (Antisense Therapeutics), CAM2029 (Camurus), Veldoreotide (Strongbridge Biopharma), CRN00808 (Crinetics Pharmaceuticals), and Lanreotide PRF (Ipsen) are set to launch. What happens when the grow...